Delay implementation of new CBP procedures for prescription medicines unless agencies can assure that genuine, lower-risk personal-use prescription medicines will not be prevented from entering the United States.

Nikki Budzinski · Illinois · Democratic

oversight impact 0.55 specificity 0.82 extraction confidence 86%

Commitment kind: outcome. Promised action: Urge HHS, FDA, DHS, and CBP to delay implementation of new procedures affecting prescription medicines absent clear assurances protecting personal-use imports.. Promised outcome: New procedures are delayed unless genuine prescription medicines for personal use that do not appear to present unreasonable risk can continue entering the United States.. Deadline: unknown; not assumed expired. As a U.S. Representative for Illinois' 13th District, Nikki Budzinski was listed as a signer of an October 2, 2026 congressional letter concerning CBP procedures scheduled to take effect October 22, 2026.

Contest this claim

Occurrences

“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.

Budzinski signed a congressional letter urging HHS, FDA, DHS, and CBP to delay new prescription-medicine import procedures unless they can assure continued entry of genuine, lower-risk personal-use medicines.

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · press_release · model gpt-5.5

Evidence

verified · Source version 79317 · locator 3767

Brendan Boyle (PA-02), Nikki Budzinski (IL-13), Janelle Bynum (OR-05)

Fetched verbatim passage. AI summary (separate from source): Official House release says Budzinski was among 71 signers of a letter urging HHS, FDA, DHS, and CBP to delay the new prescription-medicine procedures absent assurances. This is concrete effort in the lookback window, not delivery.

unresolved same_term A for effort

Schakowsky, Pocan Lead 71 Members Calling for Continued Allowance of Prescription Drug Imports | Congresswoman Jan Schakowsky
primary · model gpt-5.5 · confidence 90%

Contest this evidence item

verified · Source version 79328 · locator 10577

Compliance date: The compliance date for 19 CFR 145.12(a)(2)(v) and (vi) is on October 22, 2026.

Fetched verbatim passage. AI summary (separate from source): The underlying CBP interim final rule still set an October 22, 2026 compliance date. As of the October 3, 2026 refresh, the documented deadline had not passed and no official delay or assurance was found.

unresolved same_term

Federal Register :: Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry Process
secondary · model gpt-5.5 · confidence 86%

Contest this evidence item

Assessments

Public state: pending As of 2026-10-03 · verified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

Budzinski is verified as a signer of the October 2, 2026 letter urging agencies to delay the new prescription-medicine procedures absent assurances, so there is documented candidate-attributable effort. But the verified Federal Register passage shows the relevant compliance date remained October 22, 2026, and as of October 3, 2026 that date had not yet passed; the record does not verify an agency delay or the requested assurances. Because the promised outcome is not yet resolved, this is unresolved rather than delivered or partial.

provider codex_cli · model gpt-5.5 · confidence 88%